Pfizer to settle Xeljanz suit with Teva

09-09-2021

Alex Baldwin

Pfizer to settle Xeljanz suit with Teva

Molly Woodward / Shutterstock.com

Pfizer has asked a Delaware court to drop an infringement lawsuit against Teva Pharmaceuticals over a proposed generic of its rheumatoid arthritis drug Xeljanz (tofacitinib).


Pfizer, US District Court for the District of Delaware, Teva Pharmaceuticals, ANDA, Xeljanz, Zydus Pharmaceuticals, Aurobindo

LSIPR